Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Allovir, Inc. | Director, 10%+ Owner | Common Stock | 16.7M | $13.2M | $0.79 | Jun 6, 2024 | Shares held by ElevateBio LLC |
Scholar Rock Holding Corp | Director | Common Stock | 304K | $2.73M | $8.99 | Jun 27, 2024 | Direct |
Allovir, Inc. | Director, 10%+ Owner | Common Stock | 2.14M | $1.7M | $0.79 | Jun 6, 2024 | Direct |
Seer, Inc. | Director | Class A Common Stock | 355K | $722K | $2.03 | Jun 12, 2024 | Direct |
Allovir, Inc. | Director, 10%+ Owner | Common Stock | 721K | $571K | $0.79 | Jun 6, 2024 | Shares held by The Hallal Family Irrevocable Trust 2012 |
Allovir, Inc. | Director, 10%+ Owner | Common Stock | 138K | $109K | $0.79 | Jun 6, 2024 | Shares held by Terrie A. Hallal Family Irrevocable Trust 2012 |
Seer, Inc. | Director | Stock Option (right to buy) | 34.7K | Jun 14, 2023 | Direct | ||
iTeos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24.2K | Jun 11, 2024 | Direct | ||
Scholar Rock Holding Corp | Director | Stock Option (Right to Buy) | 18K | Jun 27, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SRRK | Scholar Rock Holding Corp | Jun 27, 2024 | 2 | $0 | 4 | Jul 1, 2024 | Director |
SEER | Seer, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
ITOS | iTeos Therapeutics, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
ALVR | Allovir, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director, 10%+ Owner |
SRRK | Scholar Rock Holding Corp | Jun 21, 2023 | 1 | $0 | 4 | Jun 22, 2023 | Director |
SEER | Seer, Inc. | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
ITOS | iTeos Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
ALVR | Allovir, Inc. | May 11, 2023 | 1 | $0 | 4 | May 12, 2023 | Director, 10%+ Owner |
ALVR | Allovir, Inc. | Oct 19, 2022 | 1 | -$5.07M | 4 | Oct 21, 2022 | Director, 10%+ Owner |
ALVR | Allovir, Inc. | Sep 29, 2022 | 1 | -$2.94M | 4 | Sep 30, 2022 | Director, 10%+ Owner |
ALVR | Allovir, Inc. | Jul 28, 2022 | 1 | $15M | 4 | Aug 1, 2022 | Director, 10%+ Owner |
ALVR | Allovir, Inc. | Jul 21, 2022 | 1 | -$22.5K | 4 | Jul 21, 2022 | Director, 10%+ Owner |
SRRK | Scholar Rock Holding Corp | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
SEER | Seer, Inc. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
ITOS | iTeos Therapeutics, Inc. | Jun 8, 2022 | 13 | -$487K | 4 | Jun 10, 2022 | Director |
ALVR | Allovir, Inc. | Jun 3, 2022 | 1 | -$241K | 4 | Jun 6, 2022 | Director, 10%+ Owner |
SRRK | Scholar Rock Holding Corp | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
ALVR | Allovir, Inc. | May 17, 2022 | 1 | $0 | 4 | May 19, 2022 | Director, 10%+ Owner |
ALVR | Allovir, Inc. | Apr 21, 2022 | 1 | -$24.8K | 4 | Apr 22, 2022 | Director, 10%+ Owner |
ALVR | Allovir, Inc. | Mar 10, 2022 | 2 | -$492K | 4 | Mar 11, 2022 | Director, 10%+ Owner |
ALVR | Allovir, Inc. | Jan 24, 2022 | 1 | -$137K | 4 | Jan 25, 2022 | Director, 10%+ Owner |
ITOS | iTeos Therapeutics, Inc. | Dec 20, 2021 | 5 | -$2M | 4 | Dec 22, 2021 | Director |
SEER | Seer, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |
ITOS | iTeos Therapeutics, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
SRRK | Scholar Rock Holding Corp | May 27, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |
ALVR | Allovir, Inc. | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Director, 10%+ Owner |